For most families, private cord blood banking is optional. The major medical bodies are clear about that, and we have said so elsewhere on this site.
For a smaller group of families, the same bodies say something quite different. Where a close relative has a condition treatable by stem cell transplant, private or directed banking moves from optional to actively recommended, by the American Academy of Pediatrics among others.
This article is written to help you work out which group you are in. If you are in the second, the next step is a conversation with your doctor, not with a salesperson.

The position is more specific than either side of the marketing argument suggests.
The American Academy of Pediatrics discourages private banking as general biological insurance, and encourages public donation as the default for families with no known indication. It notes that publicly donated units are far more likely to be used than privately stored ones.
The same policy then says the opposite for a defined group. The AAP recommends cord blood banking where an infant has a full sibling with a malignant or genetic condition treatable by cord blood transplantation. The American Medical Association extends similar reasoning to a family history of such conditions. This is usually called directed donation: the newborn’s cord blood is collected and reserved specifically for the relative who may need it.
The distinction is not about whether cord blood works. It is about probability. Banking for a hypothetical future need has low expected value. Banking when a named relative already has a transplant-treatable condition has a real, identified recipient.
Note what the guidance does not say. It does not say banking guarantees a usable unit, and it does not replace the judgement of the treating transplant team. Whether a stored unit is suitable is a clinical decision made at the time.
If any of the following describes your family, raise cord blood banking with your obstetrician and, where relevant, with the specialist treating your affected relative.
| Situation | Why it matters |
|---|---|
| A sibling or close relative with leukaemia, lymphoma or another transplant-treatable cancer | The clearest indication in the guidance. A matched sibling unit can be a first-line transplant option and avoids an unrelated donor search |
| Family history of inherited blood disorders: thalassaemia major or sickle cell disease | Both are curable by allogeneic transplant. In populations with high carrier rates, these conditions account for a large share of cord blood transplants |
| A known immune deficiency in the family, such as severe combined immunodeficiency or Wiskott-Aldrich syndrome | Cord blood transplant is established treatment and outcomes are strongly better when performed early |
| An inherited metabolic disorder in the family | Conditions such as Hurler syndrome and adrenoleukodystrophy are treated with cord blood transplant, and timing is critical |
| Consanguineous marriage or a known carrier status in either parent | Raises the probability of recessive conditions. UAE and regional premarital screening data show blood disorders are the most common finding among at-risk couples |
| A child already awaiting or likely to need a stem cell transplant | Speak to the transplant team before making arrangements. They will advise on timing, suitability and whether a new unit would realistically be usable |
Two honest points belong here, because the alternative is selling you something on an incomplete picture.

Stem cell transplants depend on HLA matching, the tissue-type markers your immune system uses to distinguish your own cells from foreign ones. The closer the match, the better the outcome and the lower the risk of graft-versus-host disease.
The arithmetic within a family is fixed by inheritance:
One in four sounds modest until you compare it with the alternative. An unrelated registry search takes weeks or months, may fail, and is harder for patients of Arab, South Asian and mixed heritage, who are under-represented in global registries. A stored sibling unit is already collected, already tested, already typed and available immediately. For a family with a diagnosis in hand, that difference in time can matter more than the odds.
Families with a medical indication normally choose private or directed storage, for one reason: exclusivity. A publicly donated unit enters a registry and may be given to any matched patient, so it may not be there when your family needs it.
Abu Dhabi Biobank runs both models from the same DoH-licensed laboratory. Families with an indication can store privately with exclusive access, while families without one can donate at no cost. The processing standards and chain of custody are identical either way.

Before you commit at list price, ask. Cord blood banks in other countries commonly run reduced-cost or free programmes for families with a documented medical need, and it is a reasonable question to put to any provider. Speak to our medical advisors about your circumstances rather than enrolling online.
Two conversations matter: your obstetrician, and the specialist treating your affected relative. The second is the one most families skip and the one that most changes the answer.
Timing is unforgiving. Collection happens once, in the minutes after birth, and cannot be repeated. Arrangements should be made by around week 34 of pregnancy, earlier if a transplant decision is already in progress. Check whether your hospital is a collection partner as part of that conversation.
The American Academy of Pediatrics recommends it where an infant has a full sibling with a malignant or genetic condition treatable by cord blood transplantation. The American Medical Association extends this to a family history of such conditions. For families with no known indication, the same bodies recommend public donation instead.
Potentially, if the tissue types match and the transplant team judges the unit suitable. A full sibling has roughly a one in four chance of being a full HLA match. If the condition is recessive and inherited, the newborn may carry it too, in which case the unit cannot be used. Your transplant team decides.
Roughly one in four for a full HLA match, one in two for a half match and one in four for no match. Around 70 per cent of patients needing a transplant must look outside the family. A stored sibling unit’s advantage is availability: already collected, tested and typed, with no registry search delay.
If the condition is treatable by stem cell transplant, such as thalassaemia major, sickle cell disease, an inherited immune deficiency or a metabolic disorder, then yes, this is the situation the guidance supports. Discuss it with your obstetrician and with the specialist treating the affected relative before deciding.
Banks in several countries run free or reduced-cost programmes for families with a documented medical indication. We are not aware of a publicly advertised UAE equivalent at present. Ask any provider directly what medical-need arrangements they offer, and raise it with your treating team, who may know of options.
Arrangements should be complete by around week 34 of pregnancy, and sooner if a transplant decision is already underway. Collection happens once, in the minutes after delivery, and cannot be repeated. Confirm early that your delivery hospital is set up for collection.